2018
DOI: 10.1016/j.colsurfb.2018.05.037
|View full text |Cite
|
Sign up to set email alerts
|

In vitro evaluation of lysophosphatidic acid delivery via reverse perfluorocarbon emulsions to enhance alveolar epithelial repair

Abstract: The availability and thus the biological effect of LPA is significantly blunted during emulsified delivery in vitro, and this attenuation depends on the specific cellular function examined. Thus, the cellular level effects of drug delivery to the lungs via PFC emulsion are likely to vary based on the drug and the effect it is intended to create.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 36 publications
0
1
0
Order By: Relevance
“…•Aqueos lysophosphatidic acid [197] •Hypokalemia [198] •Estradiol [199] •Pepsin [200] •1,25-dihydroxy vitamin D3 [201] •Substance P [202] •All-trans retinoic acid receptor agonist [203] •BMS493 (retinoic acid antagonist) [203] Immune Mediators…”
Section: Increase Decrease No Impactmentioning
confidence: 99%
“…•Aqueos lysophosphatidic acid [197] •Hypokalemia [198] •Estradiol [199] •Pepsin [200] •1,25-dihydroxy vitamin D3 [201] •Substance P [202] •All-trans retinoic acid receptor agonist [203] •BMS493 (retinoic acid antagonist) [203] Immune Mediators…”
Section: Increase Decrease No Impactmentioning
confidence: 99%